Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × HhAntag691 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Pancreatic Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Meningioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Clear Cell 1 Chondrosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1

Interventions

Nivolumab 5 Specimen Handling 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 relatlimab 2 daromun 2 cemiplimab 2 Standard of Care 2 CTLA-4 Antigen 2 talimogene laherparepvec 1 sonidegib 1 prednylidene 1 deltacortene 1 X-Rays 1 Watchful Waiting 1 Vitamin D 1 Surgical Procedures, Operative 1 Sunscreening Agents 1 Sirolimus 1 Radiotherapy 1 Prednisone 1 Practice Guidelines as Topic 1 Photochemotherapy 1 Opdualag 1 Observation 1 Niacinamide 1 Mohs Surgery 1 MAPRE1 protein, human 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02667574 2026-04-22

VISMONEO

University Hospital, Lille

Phase 2 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡